Evidence map›Paper›PMID 31603991›Full record

ReviewJournal of inherited metabolic disease2020

Inborn errors of enzymes in glutamate metabolism.

Lynne Rumping, Esmee Vringer, Roderick H J Houwen, Peter M van Hasselt, Judith J M Jans, Nanda M Verhoeven-Duif

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of inherited metabolic disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Response to Shen and Zou.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  15. Article
  16. Article
  17. Inborn errors of enzymes in glutamate metabolism.Journal of inherited metabolic disease · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lynne RumpingDepartment of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Esmee VringerDepartment of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Roderick H J HouwenDepartment of Pediatrics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Peter M van HasseltDepartment of Pediatrics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Judith J M JansDepartment of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Nanda M Verhoeven-DuifDepartment of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.ORCID 0000-0002-2016-5182
Utrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glutamate is involved in a variety of metabolic pathways. We reviewed the literature on genetic defects of enzymes that directly metabolise glutamate, leading to inborn errors of glutamate metabolism. Seventeen genetic defects of glutamate metabolising enzymes have been reported, of which three were only recently identified. These 17 defects affect the inter-conversion of glutamine and glutamate, amino acid metabolism, ammonia detoxification, and glutathione metabolism. We provide an overview of the clinical and biochemical phenotypes of these rare defects in an effort to ease their recognition. By categorising these by biochemical pathway, we aim to create insight into the contributing role of deviant glutamate and glutamine levels to the pathophysiology. For those disorders involving the inter-conversion of glutamine and glutamate, these deviant levels are postulated to play a pivotal pathophysiologic role. For the other IEM however-with the exception of urea cycle defects-abnormal glutamate and glutamine concentrations were rarely reported. To create insight into the clinical consequences of disturbed glutamate metabolism-rather than individual glutamate and glutamine levels-the prevalence of phenotypic abnormalities within the 17 IEM was compared to their prevalence within all Mendelian disorders and subsequently all disorders with metabolic abnormalities notated in the Human Phenotype Ontology (HPO) database. For this, a hierarchical database of all phenotypic abnormalities of the 17 defects in glutamate metabolism based on HPO was created. A neurologic phenotypic spectrum of developmental delay, ataxia, seizures, and hypotonia are common in the inborn errors of enzymes in glutamate metabolism. Additionally, ophthalmologic and skin abnormalities are often present, suggesting that disturbed glutamate homeostasis affects tissues of ectodermal origin: brain, eye, and skin. Reporting glutamate and glutamine concentrations in patients with inborn errors of glutamate metabolism would provide additional insight into the pathophysiology.

Indexed as

Amino Acid Metabolism, Inborn ErrorsDatabases, FactualDeficiency DiseasesGlutamatesGlutamineHumansGlutamatesGlutaminebiochemical parallelsinborn errors of glutamate metabolismnewly identified IEMphenotypic parallels

Identifiers

PMID31603991
PMCPMC7078983
OpenAlexW2980102359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.